US2020131505A1PendingUtilityA1

Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection

59
Assignee: DOVETAIL GENOMICS LLCPriority: Oct 19, 2015Filed: Sep 5, 2019Published: Apr 30, 2020
Est. expiryOct 19, 2035(~9.3 yrs left)· nominal 20-yr term from priority
C12Q 1/6809C12Q 2523/101G16B 30/00C12Q 1/6806C12Q 1/6869C12N 15/1065C12Q 1/6874C12Q 2535/122C12Q 2521/301G16B 50/00C12Q 1/68C12N 15/11G16B 30/20G16B 30/10Y02A90/10
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosure provides methods for haplotype phasing and meta-genomics assemblies. The disclosure provides a streamlined method for accomplishing these tasks, such that intermediates need not be labeled by an affinity label to facilitate binding to a solid surface. The disclosure also provides methods and compositions for the de novo generation of scaffold information, linkage information, and genome information for unknown organisms in heterogeneous metagenomic samples or samples obtained from multiple individuals. Practice of the methods can allow de novo sequencing of entire genomes of uncultured or unidentified organisms in heterogeneous samples, or the determination of linkage information for nucleic acid molecules in samples comprising nucleic acids obtained from multiple individuals.

Claims

exact text as granted — not AI-modified
1 .- 22 . (canceled) 
     
     
         23 . A method of determining genomic linkage information for a heterogeneous nucleic acid sample comprising: (a) obtaining a stabilized heterogeneous nucleic acid sample, wherein the stabilized heterogeneous nucleic acid sample comprises a plurality of DNA segments each of the plurality of DNA segments held together independent of their common phosphodiester backbone, wherein the common phosphodiester backbone is cleaved to create exposed DNA ends; (b) labeling the exposed DNA ends to form labeled exposed DNA ends; (c) ligating the labeled exposed DNA ends to form labeled paired ends; (d) sequencing across the labeled paired ends to generate a plurality of paired sequence reads; and (e) assigning each half of a paired sequence read of the plurality of paired sequence reads to a common nucleic acid molecule of origin. 
     
     
         24 . The method of  claim 23 , wherein the stabilized heterogeneous nucleic acid sample is from a cancer sample. 
     
     
         25 . The method of  claim 23 , wherein the stabilized heterogeneous nucleic acid sample is from a metagenomic sample. 
     
     
         26 . The method of  claim 23 , wherein labeling the exposed DNA ends comprises adding a plurality of oligos to the exposed DNA ends. 
     
     
         27 . The method of  claim 26 , wherein DNA segments of the plurality of DNA segments having a common oligo sequence are assigned to a common scaffold. 
     
     
         28 . The method of  claim 27 , comprising mapping each half of the paired sequence read to a contig dataset, and including any matching contig of the contig dataset into the common scaffold. 
     
     
         29 . The method of  claim 28 , wherein the contig dataset is concurrently generated. 
     
     
         30 . The method of  claim 28 , wherein the contig dataset is obtained from a database. 
     
     
         31 . The method of  claim 23 , wherein labeling the exposed DNA ends comprises ligating at least a first exposed DNA end to at least a second exposed DNA end of the plurality of DNA segments. 
     
     
         32 . The method of  claim 31 , comprising mapping each half of the paired sequence read to a contig dataset, and including any matching contig of the contig dataset into the common scaffold. 
     
     
         33 . The method of  claim 32 , wherein the contig dataset is concurrently generated. 
     
     
         34 . The method of  claim 32 , wherein the contig dataset is obtained from a database. 
     
     
         35 . The method of  claim 23 , wherein the common phosphodiester backbone is cleaved subsequent to obtaining the stabilized heterogeneous nucleic acid sample. 
     
     
         36 . The method of  claim 23 , wherein the stabilized heterogeneous nucleic acid sample is contacted to a crosslinking agent. 
     
     
         37 . The method of  claim 23 , wherein the stabilized heterogeneous nucleic acid sample is an FFPE sample. 
     
     
         38 . The method of  claim 23 , comprising contacting the stabilized heterogeneous nucleic acid sample to a reverse transcriptase. 
     
     
         39 . The method of  claim 23 , wherein sequence reads from the DNA segments assemble into at least two nucleic acid scaffolds, such that at least 50% of a first genome and at least 50% of a second genome are represented in the at least two nucleic acid scaffolds. 
     
     
         40 . The method of  claim 23 , wherein the common nucleic acid molecule of origin maps to a single individual. 
     
     
         41 . The method of  claim 23 , wherein the common nucleic acid molecule of origin identifies a subset of a population. 
     
     
         42 . The method of  claim 23 , wherein the method comprises using SPRI beads. 
     
     
         43 . The method of  claim 23 , wherein the stabilized heterogeneous nucleic acid sample comprises no greater than about 5 micrograms of DNA.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.